DEPODUR (MORPHINE SULFATE) — FDA Approval NDA021671 (PACIRA PHARMS INC)
DEPODUR (MORPHINE SULFATE) — FDA Approval NDA021671 (PACIRA PHARMS INC) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: DEPODUR; Active ingredients: MORPHINE SULFATE; Application number: NDA021671.
| Brand name | DEPODUR |
|---|---|
| Active ingredients | MORPHINE SULFATE |
| Application number | NDA021671 |
| Sponsor | PACIRA PHARMS INC |
| Dosage form | INJECTABLE, LIPOSOMAL |
| Route | EPIDURAL |
| Marketing status | Discontinued |
| Products in application | 3 |
| First approval date | 20040518 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →